EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Microbiome-Based Precision Interventions in Type 2 Diabetes Mellitus: Mechanisms, Modulators, and Translational Opportunities

Davini Clister, Qhelen Mayline Chandra, Michle William Tan, Mega Carensia Gunawan, Aasia Bibi, Amer Ahmed, Marianne Bastian, Pornphimon Meesakul, Shugeng Cao, Bonglee Kim, Fahrul Nurkolis, Rony Abdi Syahputra

The Journal of Nutrition · 2026-07 · 156 (7) · 101596

DOI: 10.1016/j.tjnut.2026.101596 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Nutrition, 2026-07. Verfasst von Davini Clister und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Precision Medicine, Gastrointestinal Microbiome, Microbiota. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 313 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea, Kementerian Pendidikan Nasional, Universitas Sumatera Utara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is a complex metabolic disease driven by insulin resistance, chronic low-grade inflammation, and impaired glucose regulation. Although pharmacological options have advanced, sustained glycemic control remains elusive due to heterogeneity in disease progression and therapeutic response. Precision medicine offers a framework to individualize interventions, with the gut microbiota emerging as a central determinant of host metabolic and immune regulation. Dysbiosis has been implicated in T2DM through altered microbial metabolites-including short-chain fatty acids, bile acids, branched-chain amino acids, and indole derivatives-that shape insulin sensitivity, inflammatory pathways, and glucose homeostasis. This review critically examined microbiome-targeted strategies such as probiotics, prebiotics, synbiotics, fecal microbiota transplantation, and personalized nutrition, alongside advances in metagenomics and machine learning for biomarker discovery. By integrating mechanistic and translational insights, we highlight opportunities and challenges in implementing microbiome-based precision interventions, underscoring their potential to transform T2DM management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Precision MedicineGastrointestinal MicrobiomeMicrobiotaHumansProbioticsPrebioticsFecal Microbiota TransplantationSynbioticsDysbiosisAnimals

Stichwörter der Autor:innen

gut microbiotamicrobial metabolitesprecision medicineprobioticssynbioticstype 2 diabetes mellitus

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia.
  • Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari Aldo Moro, Bari, Italy.
  • Department of Pharmaceutical Sciences, Daniel K. Inouye College of Pharmacy, University of Hawai'i at Hilo, Hilo, HI, United States.
  • Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
  • Department of Biological Sciences, Faculty of Sciences and Technology, State Islamic University of Sunan Kalijaga, Yogyakarta, Indonesia; Medical Research Center of Indonesia, Surabaya, Indonesia; Master of Basic Medica…
  • Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia. Electronic address: rony@usu.ac.id.

Förderung

  • Ministry of Science and ICT, South Korea
  • Kementerian Pendidikan Nasional
  • Universitas Sumatera Utara
  • Universitas Pendidikan Indonesia
  • Korea Health Industry Development Institute
  • Kyung Hee University
  • National Research Foundation of Korea
  • Universitas Hasanuddin

Zitieren

APA

Clister, D., Chandra, Q. M., Tan, M. W., Gunawan, M. C., Bibi, A., Ahmed, A., Bastian, M., Meesakul, P., Cao, S., Kim, B., Nurkolis, F., & Syahputra, R. A. (2026). Microbiome-Based Precision Interventions in Type 2 Diabetes Mellitus: Mechanisms, Modulators, and Translational Opportunities. The Journal of Nutrition, 156(7), 101596. https://doi.org/10.1016/j.tjnut.2026.101596

Vancouver

Clister D, Chandra QM, Tan MW, Gunawan MC, Bibi A, Ahmed A, et al. Microbiome-Based Precision Interventions in Type 2 Diabetes Mellitus: Mechanisms, Modulators, and Translational Opportunities. The Journal of Nutrition. 2026;156(7):101596. doi:10.1016/j.tjnut.2026.101596

BibTeX
@article{Clister2026,
  author = {Clister, Davini and Chandra, Qhelen Mayline and Tan, Michle William and Gunawan, Mega Carensia and Bibi, Aasia and Ahmed, Amer and Bastian, Marianne and Meesakul, Pornphimon and Cao, Shugeng and Kim, Bonglee and Nurkolis, Fahrul and Syahputra, Rony Abdi},
  title = {Microbiome-Based Precision Interventions in Type 2 Diabetes Mellitus: Mechanisms, Modulators, and Translational Opportunities},
  journal = {The Journal of Nutrition},
  year = {2026},
  volume = {156},
  number = {7},
  pages = {101596},
  doi = {10.1016/j.tjnut.2026.101596}
}
Kostenlos starten →